FIDSON HEALTHCARE PLC — Ofloxacin Importer Profile
Pharmaceutical Importer · #17 buyer for Ofloxacin · $2.8M import value · 63 shipments · NIGERIA · DGFT Verified
FIDSON HEALTHCARE PLC is the #17 importer of Ofloxacin from India with $2.8M in import value and 63 verified shipments. FIDSON HEALTHCARE PLC holds a 0.6% market share in Ofloxacin imports based in NIGERIA. The company sources from 1 verified supplier across 38 formulations shipped to 1 country. Overall, FIDSON HEALTHCARE PLC imports 7 pharmaceutical products worth $8.3M across 4 therapeutic categories.
FIDSON HEALTHCARE PLC — Ofloxacin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ofloxacin to FIDSON HEALTHCARE PLC?
Verified from 63 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| V S INTERNATIONAL PRIVATE LIMITED | $2.8M | 63 | 100.0% |
FIDSON HEALTHCARE PLC sources Ofloxacin from 1 verified Indian supplier based on 63 customs records. The primary supplier is V S INTERNATIONAL PRIVATE LIMITED accounting for 100.0% of imports.
How Does FIDSON HEALTHCARE PLC Compare to Nearest Ofloxacin Importers?
Buyers ranked immediately above and below #17 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | RISING PHARMA HOLDINGS, INC. | UNITED STATES | $3.0M | 61 | $50.0K |
| 16 | LEADING PHARMA | UNITED STATES | $2.1M | 43 | $50.0K |
| 17 | FIDSON HEALTHCARE PLC ★ | NIGERIA | $1.6M | 33 | $50.0K |
| 15 | AO RANBAXY | RUSSIA | $1.4M | 28 | $50.0K |
| 2 | DR, REDDYS LABORATORIES, INC | UNITED STATES | $1.2M | 24 | $50.0K |
FIDSON HEALTHCARE PLC ranks #17 among 3,093 Ofloxacin importers from India. Average shipment value of $50.0K compared to the market average of $7.2K. The closest competitors by value are RISING PHARMA HOLDINGS, INC. and LEADING PHARMA.
Where Does FIDSON HEALTHCARE PLC Import Ofloxacin To?
Destination countries from 63 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $2.8M | 63 | 100.0% |
FIDSON HEALTHCARE PLC imports Ofloxacin to 1 country. The primary destination is NIGERIA receiving 100.0% of shipments worth $2.8M.
What Ofloxacin Formulations Does FIDSON HEALTHCARE PLC Import?
| Formulation | Value | Shipments |
|---|---|---|
| CIPROTAB 500-CIPROFLOXACIN TABLETS USP 5 | $250.0K | 5 |
| CIPROTAB 500- CIPROFLOXACIN TABLETS USP500 MG PACK: 1X10'SNOS | $208.1K | 6 |
| CIPROTAB 500- Ciprofloxacin Tablets USP | $200.0K | 4 |
| CIPROTAB 500- CIPROFLOXACIN TABLETS USP500 MG PACK: 1X10S | $150.0K | 3 |
| CIPROTAB 500- CIPROFLOXACIN TABLETS USP500 MG PACK: 1X14'SNOS | $144.7K | 3 |
| CIPROTAB 500 - CIPROFLOXACIN TABLETS USP500 MG ( PACK-1 X 14S) | $139.9K | 3 |
| CIPROTAB 500 - CIPROFLOXACIN TABLETS USP500 MG ( PACK-1 X 10S) | $137.6K | 3 |
| CIPROTAB 500-CIPROFLOXACIN HYDRACHLORIDE | $100.0K | 2 |
| CIPROTAB 500- Ciprofloxacin Hydrochloride USP 500 mg | $100.0K | 2 |
| CIPROTAB 500- CIPROFLOXACIN TABLETS USP500 MG PACK: 1X14S | $100.0K | 2 |
FIDSON HEALTHCARE PLC imports 38 distinct Ofloxacin formulations from India. The top formulation is CIPROTAB 500-CIPROFLOXACIN TABLETS USP 5 with 5 shipments worth $250.0K.
Regulatory Requirements: Importing Ofloxacin into Nigeria
What FIDSON HEALTHCARE PLC and other importers must comply with to import Ofloxacin from India
Regulatory Authority
National Agency for Food and Drug Administration and Control (NAFDAC)
Approval Process for Generic Ofloxacin
Drug registration under NAFDAC guidelines. Requires quality data, stability studies, and WHO-type Certificate of Pharmaceutical Product (CPP) from India.
Typical timeline: 6–18 months
GMP Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Import Licence & Documentation
NAFDAC import permit; Certificate of Pharmaceutical Product (CPP) from CDSCO India
Labeling & Packaging
English language labeling; NAFDAC registration number required
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified inspections of Indian sites in recent years.
Regulatory information is provided for general reference based on publicly available NAFDAC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with NAFDAC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ofloxacin from India and How Much Does FIDSON HEALTHCARE PLC Import?
India exported $22.2M worth of Ofloxacin through 15,000 shipments from 1094 suppliers to 180 countries, serving 3,093 buyers globally. FIDSON HEALTHCARE PLC imports $2.8M of this total, accounting for 0.6% of India's Ofloxacin exports with 63 shipments from NIGERIA. This is verified from 63 customs shipment records covering 38 distinct formulations.
What Is the Average Order Value for FIDSON HEALTHCARE PLC's Ofloxacin Imports?
FIDSON HEALTHCARE PLC's average Ofloxacin order value is $44.5K per consignment, based on 63 shipments totaling $2.8M. FIDSON HEALTHCARE PLC is based in NIGERIA and ranks #17 among all Ofloxacin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ofloxacin to FIDSON HEALTHCARE PLC?
FIDSON HEALTHCARE PLC sources Ofloxacin from 1 verified Indian supplier: V S INTERNATIONAL PRIVATE LIMITED ($2.8M, 100.0%). This is based on 63 customs records.
How Does FIDSON HEALTHCARE PLC Compare to Other Ofloxacin Importers?
FIDSON HEALTHCARE PLC ranks #17 among 3,093 Ofloxacin importers from India with a 0.6% market share. The top 3 importers are LIFESTAR PHARMA LLC ($5.8M), LLC SENTISS RUS ($3.1M), RISING PHARMA HOLDINGS, INC. ($3.0M). FIDSON HEALTHCARE PLC processed 63 shipments from NIGERIA.
What Other Advanced Antibiotics Products Does FIDSON HEALTHCARE PLC Import?
FIDSON HEALTHCARE PLC also imports these advanced antibiotics products. Each links to the detailed product page.
About FIDSON HEALTHCARE PLC
FIDSON HEALTHCARE PLC imports 7 products worth $8.3M. Beyond Ofloxacin, top products include Ciprofloxacin, Glucosamine, Cefuroxime, Chondroitin, Tinidazole. View the complete FIDSON HEALTHCARE PLC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: FIDSON HEALTHCARE PLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as FIDSON HEALTHCARE PLC's capped import value divided by total capped export value for Ofloxacin across all Indian exporters.
- 5.Verified Records: This page is backed by 63 individual customs records matching FIDSON HEALTHCARE PLC importing Ofloxacin, covering 38 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,093+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ofloxacin Import Data for FIDSON HEALTHCARE PLC
Access order-level details, pricing data, supplier connections, and competitive analysis for FIDSON HEALTHCARE PLC's Ofloxacin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FIDSON HEALTHCARE PLC
Full Company Profile →
7 products · $8.3M total trade · 4 categories
FIDSON HEALTHCARE PLC × Ofloxacin
Verified from customs records
Company Overview
Top Products by FIDSON HEALTHCARE PLC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for FIDSON HEALTHCARE PLC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ofloxacin. For current order-level data, contact TransData Nexus.